ArticleAlimentary pharmacology & therapeutics2025

Long-Term Outcomes of an Infliximab-First Versus Vedolizumab-First Treatment Strategy in Biologic-Naïve Patients With Ulcerative Colitis.

Austin Haynesworth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.